Mycobacterium Tuberculosisresistance to Isoniazid and Rifampicin in a Hiv-1 Endemic Population in Western Kenya in 2014

BMJ Global Health - United Kingdom
doi 10.1136/bmjgh-2016-000260.84
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Isoniazid- And Rifampicin-Induced Thrombocytopenia

Multidisciplinary Respiratory Medicine
PulmonaryRespiratory Medicine
2013English

Genotyping and Rifampicin and Isoniazid Resistance in Mycobacterium Bovis Strains Isolated From the Lymph Nodes of Slaughtered Cattle

Tuberculosis
Infectious DiseasesImmunologyMicrobiology
2017English

Isoniazid and Rifampicin as Therapeutic Regimen in the Current Era: A Review

Journal of Tuberculosis Research
2014English

Acetylation of Isoniazid - A Novel Mechanism of Isoniazid Resistance in Mycobacterium Tuberculosis

2020English

Serum Total Bile Acid Levels in Patients Receiving Rifampicin and Isoniazid

Annals of Clinical Biochemistry
MedicineClinical Biochemistry
1984English

Co-Encapsulation of Rifampicin and Isoniazid in Crude Soybean Lecithin Liposomes

South African Journal of Chemistry
Chemistry
2019English

HIV Testing and Counselling Experiences: A Qualitative Study of Older Adults Living With HIV in Western Kenya

BMC Geriatrics
GerontologyGeriatrics
2018English

Do We Need to Detect Isoniazid Resistance in Addition to Rifampicin Resistance in Diagnostic Tests for Tuberculosis?

PLoS ONE
Multidisciplinary
2014English

Dosage of Isoniazid and Rifampicin Poorly Predicts Drug Exposure in Tuberculosis Patients

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy